Akoya Biosciences (AKYA) Insider Trading & Ownership $1.29 -0.07 (-5.15%) Closing price 07/7/2025 07:39 PM EasternExtended Trading$1.29 0.00 (0.00%) As of 07/7/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Akoya Biosciences (NASDAQ:AKYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$1.21MNumber OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$1.05M Get AKYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Akoya Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AKYA Insider Buying and Selling by Quarter Akoya Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/11/2024Brian MckelligonCEOSell7,500$2.08$15,600.00 6/6/2024Brian MckelligonCEOSell7,500$2.01$15,075.00 3/20/2024Brian MckelligonCEOSell7,500$4.97$37,275.00 3/13/2024Brian MckelligonCEOSell7,500$4.94$37,050.00 12/19/2023Brian MckelligonCEOSell7,500$4.48$33,600.00 9/7/2023Frederic PlaCOOBuy20,000$4.60$92,000.00 6/12/2023John Frederick EkCFOBuy20,000$5.00$100,000.00 6/12/2023Matthew WinklerDirectorBuy203,388$5.00$1,016,940.00 6/6/2023Brian MckelligonCEOSell5,000$5.71$28,550.00 12/14/2022Joseph DriscollCFOSell24,613$12.54$308,647.02 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/13/2022Garry Ph.D. NolanDirectorSell100$13.25$1,325.00 12/2/2022Garry Ph.D. NolanDirectorSell1,100$13.25$14,575.00 11/16/2022Garry Ph.D. NolanDirectorSell300$13.25$3,975.00 11/14/2022Garry Ph.D. NolanDirectorSell600$13.28$7,968.00 11/10/2022Garry Ph.D. NolanDirectorSell3,810$13.31$50,711.10 9/14/2022Garry Ph.D. NolanDirectorSell8,305$13.26$110,124.30 9/12/2022Garry Ph.D. NolanDirectorSell1,800$13.30$23,940.00 9/9/2022Garry Ph.D. NolanDirectorSell22,191$13.31$295,362.21 9/7/2022Brian MckelligonCEOSell5,000$12.83$64,150.00 (Data available from 1/1/2013 forward) AKYA Insider Trading Activity - Frequently Asked Questions Who is on Akoya Biosciences' Insider Roster? The list of insiders at Akoya Biosciences includes Brian Mckelligon, Frederic Pla, Garry Ph.D. Nolan, John Frederick Ek, Joseph Driscoll, and Matthew Winkler. Learn more on insiders at AKYA. What percentage of Akoya Biosciences stock is owned by insiders? 7.30% of Akoya Biosciences stock is owned by insiders. Learn more on AKYA's insider holdings. Which Akoya Biosciences insiders have been buying company stock? The following insider purchased AKYA shares in the last 24 months: Frederic Pla ($92,000.00). How much insider buying is happening at Akoya Biosciences? Insiders have purchased a total of 20,000 AKYA shares in the last 24 months for a total of $92,000.00 bought. Which Akoya Biosciences insiders have been selling company stock? The following insider sold AKYA shares in the last 24 months: Brian Mckelligon ($138,600.00). How much insider selling is happening at Akoya Biosciences? Insiders have sold a total of 37,500 Akoya Biosciences shares in the last 24 months for a total of $138,600.00 sold. Akoya Biosciences Key ExecutivesMr. Brian McKelligon (Age 55)President, CEO & Director Compensation: $854.99kMr. John Frederick Ek (Age 48)CFO, Principal Financial Officer & Principal Accounting Officer Compensation: $496.76kDr. Frederic G. Pla Ph.D. (Age 65)Chief Operating Officer Compensation: $581.23kPriyam ShahSenior Director of Business Development & Investor Relations StrategyMs. Jennifer Kamocsay (Age 53)General Counsel Dr. Niro Ramachandran Ph.D. (Age 49)Chief Business Officer Compensation: $298.18kDr. Pascal Bamford Ph.D.Senior Vice President, Research & Development and Laboratory OperationsMr. Rob C. Hart CFAJ.D., Secretary More Insider Trading Tools from MarketBeat Related Companies 908 Devices Insider Ownership Frequency Electronics Insider Ownership Kewaunee Scientific Insider Ownership Rapid Micro Biosystems Insider Ownership Owlet Insider Ownership Seer Insider Ownership Odysight.ai Insider Ownership inTEST Insider Ownership Nautilus Biotechnology Insider Ownership Optex Systems Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors? This page (NASDAQ:AKYA) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKYA Stock Alerts